Elaitra

📍 London, United Kingdom🗓 Founded 2015👥 4 employees💰 Last funded Jun 2023
More women are killed by breast cancer than any other. Our unique AI augments radiologists interpreting 3D X-Rays called Tomos. With ViewFinder, our AI which is FDA-cleared, they read faster, more accurately and more confidently. Our tech outperformed Google Health / DeepMind (Nature, 2020) with 55% fewer errors, and we had the highest single-model performances in the DREAMS Digital Mammography $1 million Challenge which had 1,200 entrants worldwide. We are working with the USA and UKs leading DBT clinicians, industry partners including NVIDIA and IBM and others. We are founder members of the London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare, established as part of the UK Government’s Industrial Strategy Challenge Fund. We are working with the UKs leading DBT clinicians, industry partners including NVIDIA and IBM and others. We are founder members of the London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Elaitra?
Elaitra has 1 investors on record on gritt.io and 1 late-stage investors.
When did Elaitra last raise funding?
The most recent investment in Elaitra recorded on gritt.io was in June 2023.
When was Elaitra founded?
Elaitra was founded in 2015.
What industry is Elaitra in?
Elaitra operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Elaitra based?
Elaitra is headquartered in London, United Kingdom.